Roberta Horth

6 ta ish

Centers for Disease Control and Prevention

1. Prevalence of hepatitis B surface antibody among previously vaccinated healthcare workers in Tashkent, Uzbekistan

   Rafail Ibragimov, Dilyara Nabirova, Alfiya Denebaeva +2

   MaqolaOAOchiq kirishHepatitis B Virus StudiesHuman Vaccines & Immunotherapeutics20241 iqtibos

   ABIABI:AkademIndex/2024.article.002532

2. 1528. Retrospective cohort study of factors associated with non-initiation of antiretroviral therapy among adults newly diagnosed with HIV in Andijan, Uzbekistan, 2018-2021

   Shokhruh Usmanov, Roberta Horth, Alfiya Denebayeva +5

   MaqolaOAOchiq kirishHIV, Drug Use, Sexual RiskOpen Forum Infectious Diseases20230 iqtibos

   ABIABI:AkademIndex/2023.article.011665

3. 2389. Surveillance evaluation of COVID-19 pharmacovigilance—Karakalpakstan, Uzbekistan, 2022

   Yunis Tursinov, Botirjon Kurbanov, Alfiya Denebayeva +2

   MaqolaOAOchiq kirishSARS-CoV-2 and COVID-19 ResearchOpen Forum Infectious Diseases20230 iqtibos

   ABIABI:AkademIndex/2023.article.011666

4. COVID-19 vaccination pharmacovigilance in Khojaly district, Uzbekistan: an epidemiological evaluation

   Yunis Tursinov, Roberta Horth, Б. Курбонов +3

   MaqolaOAOchiq kirishPharmacovigilance and Adverse Drug ReactionsFrontiers in Public Health20250 iqtibos

   ABIABI:AkademIndex/2025.article.006764

5. P-1323. Forecasting the incidence of acute respiratory infections in Uzbekistan, 2022-2023

   Rafail Ibragimov, Dilyara Nabirova, Roberta Horth +1

   MaqolaOAOchiq kirish20250 iqtibos

   ABIABI:AkademIndex/2025.article.033786

6. P-2202. Immune response after hepatitis B vaccination among healthcare providers in Uzbekistan

   Rafail Ibragimov, Roberta Horth, Dilyara Nabirova +2

   MaqolaOAOchiq kirish20250 iqtibos

   ABIABI:AkademIndex/2025.article.033788